Related Experiment Video
Updated: Jul 30, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Baseline modern medical management in the BEST-CLI trial
Matthew T Menard1, Michael R Jaff2, Alik Farber3
1Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Optimal medical therapy (OMT) adherence is low in patients with chronic limb-threatening ischemia (CLTI). Only 25% of patients met all four OMT criteria at trial entry, highlighting a gap in care for advanced peripheral atherosclerosis.
Area of Science:
- Vascular Surgery
- Cardiology
- Internal Medicine
- Clinical Trials
Background:
- Optimal medical therapy (OMT) is crucial for managing patients with chronic limb-threatening ischemia (CLTI).
- The adherence to guideline-based OMT in CLTI patients has not been extensively studied.
- The Best Endovascular vs Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial provides a unique opportunity to evaluate OMT use.
Purpose of the Study:
- To assess the utilization of guideline-based optimal medical therapy (OMT) in patients with chronic limb-threatening ischemia (CLTI) at the time of enrollment in the BEST-CLI trial.
- To identify factors associated with OMT adherence in this patient population.
Main Methods:
- A multidisciplinary committee defined OMT criteria including blood pressure, diabetes management, lipid-lowering, antiplatelet use, and smoking status.
- Data on baseline demographics, comorbidities, and OMT adherence were collected for 1830 randomized patients in the BEST-CLI trial.
- A linear regression model was employed to determine predictors of OMT use.
Main Results:
- At randomization, a high prevalence of comorbidities was observed: 87% hypertension, 69% diabetes, 73% hyperlipidemia, and 35% current smokers.
- Adherence to OMT was modest, with only 25% of patients meeting all four defined criteria (controlled blood pressure, non-smoking, lipid-lowering medication, antiplatelet agent).
- Older age (≥80 years), coronary artery disease, diabetes, and Hispanic ethnicity were positively associated with OMT use, while Black race showed a negative association.
Conclusions:
- A significant proportion of patients with CLTI in the BEST-CLI trial did not meet guideline-based OMT recommendations upon enrollment.
- These findings indicate a substantial gap in the medical management of patients with advanced peripheral atherosclerosis and CLTI.
- Future analyses will examine changes in OMT adherence and its impact on clinical outcomes and quality of life throughout the trial.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Related Concept Videos
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Blinding
Clinical Trials: Overview
Mitral Stenosis III: Medical Management
Heart Failure V: Medical Management
Rheumatic Heart Disease III: Medical Management